CJC-1295

Growth hormone axisNot approved; research useBanned in sport (WADA)

Also known as: With DAC, or without DAC (Mod GRF 1-29)

A modified GHRH analog that raises growth hormone and IGF-1. Comes in a long-acting (DAC) and short-acting form.

Educational reference, not medical advice. Many compounds here are not approved, and products sold as research chemicals are not checked for purity. Plan any use with a licensed clinician.

How it works

Binds the GHRH receptor on the pituitary. The DAC version binds albumin in blood, so a single shot keeps GH elevated for about a week.

Evidence by goal

GoalGradeWhat the grade means
Muscle & growth hormoneCLimited human data, case series or practitioner reports
Fat loss & weightCLimited human data, case series or practitioner reports
SleepCLimited human data, case series or practitioner reports
Injury & tissue repairCLimited human data, case series or practitioner reports

At a glance

Route
Subcutaneous
Half-life
With DAC: 6 to 8 days. Without DAC: about 30 minutes

Reported dosing

With DAC: 1 to 2 mg once weekly (practitioner reports). Without DAC: 100 mcg 1 to 3 times daily, usually with a GHRP.

Timing: Without DAC: fasted, at least 2 hours after eating, often before bed. With DAC: same day weekly.

Cycle: Commonly 8 to 12 weeks on, then 4 weeks off.

From approved labels where they exist, otherwise from published trials and practitioner reports.

Side effects

  • Flushing, headache, injection-site reactions
  • Water retention, numbness or tingling in hands
  • Raised blood sugar

Who should avoid it

  • Active cancer
  • Pregnancy
  • Uncontrolled diabetes

Often combined with

Very commonly combined with ipamorelin (same syringe, without DAC) for a stronger GH pulse.

Key findings

One human study (JCEM 2006): a single dose raised GH 2 to 10 fold for 6+ days and IGF-1 1.5 to 3 fold. Clinical development stopped after Phase 2.

2026 update

Clinical development stopped in 2006 after a trial participant died; the cause was not established.

Where it is legal (Oct 2026)

USNot approved
CanadaNot approved
MexicoNot approved
EUNot approved

Sources

Open CJC-1295 in the Peptide Guide Compare all peptides by goal

Last reviewed November 2026. Regulatory status reflects the US unless noted and changes often.

Natoorales and e4life.io (Mexico residency and immigration help) are sister businesses founded by Ian Kain.

Scroll to Top